Please login to the form below

Not currently logged in
Email:
Password:

study

This page shows the latest study news and features for those working in and with pharma, biotech and healthcare.

Acceleron scraps rare muscular dystrophy drug

Acceleron scraps rare muscular dystrophy drug

The US biotech took the decision to pull ACE-083 after a sift through the secondary endpoint data from the study convinced it that its clinical profile wasn’t strong enough ... TGF beta protein inhibitor ACE-083 – which inhibits proteins involved in

Latest news

More from news
Approximately 4 fully matching, plus 3,396 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 432 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 55 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 32 fully matching, plus 368 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics